Atlas Trials

Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?

Clinical trial NCT01048268 · COMPLETED

Trial details

NCT number
NCT01048268
Sponsor
University Hospital, Gentofte, Copenhagen
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2009-12-01
Primary completion
2014-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.